Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MD VIROLOGIST's Profile
Displaying 451-500 of 672 result(s).
CYDY CytoDyn Inc
12/11/2020 10:11:56 PM
I am in no way disagreeing with you (1)
CYDY CytoDyn Inc
12/11/2020 9:47:36 PM
You mean the front line health care
CYDY CytoDyn Inc
12/11/2020 9:15:35 PM
The shorter version: https://www.md (4)
CYDY CytoDyn Inc
12/11/2020 8:08:41 PM
For those interested, one of the mo (4)
CYDY CytoDyn Inc
12/11/2020 11:56:33 AM
The samples do not exist and the te (2)
CYDY CytoDyn Inc
12/09/2020 10:43:54 PM
Ask NP tomorrow.
CYDY CytoDyn Inc
12/09/2020 10:25:46 PM
This is not a hit job or a short at (3)
CYDY CytoDyn Inc
12/09/2020 9:48:11 PM
It is not a spoof. No way in the le (1)
RLFTF Mondobiotech Holding AG Basel
11/17/2020 9:59:03 AM
Where is he speaking?
CYDY CytoDyn Inc
11/11/2020 6:35:26 PM
Hi everybody, I thought I should sh (5)
CYDY CytoDyn Inc
11/10/2020 9:39:16 PM
Well said there could be a small bu
CYDY CytoDyn Inc
11/10/2020 6:14:58 PM
Well I may look at this in a differ (6)
RLFTF Mondobiotech Holding AG Basel
11/10/2020 2:12:34 PM
Oh I have a feeling EUA is near... (2)
RLFTF Mondobiotech Holding AG Basel
11/10/2020 1:42:03 PM
As a physician, well stated, the o/ (2)
CYDY CytoDyn Inc
11/08/2020 5:26:29 PM
Off label with current P&T oversite
CYDY CytoDyn Inc
11/08/2020 5:23:36 PM
Wallerian degradation?
RLFTF Mondobiotech Holding AG Basel
11/07/2020 10:04:18 AM
The drug's huge potential will be t (2)
RLFTF Mondobiotech Holding AG Basel
11/05/2020 1:20:59 PM
Phase bio suspended the trial due t (2)
CYDY CytoDyn Inc
11/04/2020 7:55:30 PM
Absolutely correct, don't believe t (1)
CYDY CytoDyn Inc
11/02/2020 11:34:00 PM
Whether right or wrong, look at the (1)
CYDY CytoDyn Inc
11/02/2020 11:25:47 PM
NeuroRx has already received EAP in
CYDY CytoDyn Inc
11/02/2020 8:04:02 PM
Yes Rub, your interpretations are j
CYDY CytoDyn Inc
11/01/2020 9:56:02 PM
From what I researched 18.2 cash on (1)
CYDY CytoDyn Inc
10/31/2020 8:37:30 PM
I did my best to get back to the DM (2)
CYDY CytoDyn Inc
10/31/2020 11:39:41 AM
To all of those who sent DM's to me (2)
CYDY CytoDyn Inc
10/30/2020 9:54:10 PM
More importantly we only talk scien (4)
CYDY CytoDyn Inc
10/30/2020 9:50:27 PM
Yes I spent two great days with him (9)
CYDY CytoDyn Inc
10/27/2020 12:03:42 PM
Just providing factual information, (1)
CYDY CytoDyn Inc
10/27/2020 8:52:31 AM
There is lab panel for long haulers
CYDY CytoDyn Inc
10/26/2020 9:41:09 PM
Leronilmab is not being considered
CYDY CytoDyn Inc
10/26/2020 9:38:28 PM
I agree but I think a doubled board
CYDY CytoDyn Inc
10/26/2020 10:37:05 AM
The case for not un blinding sectio (4)
CYDY CytoDyn Inc
10/12/2020 8:11:34 PM
Yes he has already been spending ti
CYDY CytoDyn Inc
10/08/2020 3:42:46 PM
Nice review; but also the soluble A
CYDY CytoDyn Inc
10/05/2020 7:19:09 PM
It was not mono-therapy for POTUS.
CYDY CytoDyn Inc
10/05/2020 6:00:04 PM
I don't think so. I am keeping my p
CYDY CytoDyn Inc
10/05/2020 4:07:53 PM
What I posted was a guideline, not
CYDY CytoDyn Inc
10/05/2020 4:06:09 PM
Well to all that speculated that PO (1)
CYDY CytoDyn Inc
10/05/2020 12:30:43 PM
Recommendations for Patients with C
RLFTF Mondobiotech Holding AG Basel
10/05/2020 12:21:53 PM
Maybe my post was misunderstood, I (1)
CYDY CytoDyn Inc
10/04/2020 8:01:40 PM
From "up to date": Patients with se
CYDY CytoDyn Inc
10/04/2020 7:41:39 PM
Yes
CYDY CytoDyn Inc
10/04/2020 7:36:03 PM
Dex vs hydrocortisone is based on d
CYDY CytoDyn Inc
10/04/2020 6:47:38 PM
That was in the severe to critical,
CYDY CytoDyn Inc
10/04/2020 4:00:35 PM
Based on the RECOVER study in the U
CYDY CytoDyn Inc
10/04/2020 3:53:30 PM
No from WSU school of Medicine 1986
CYDY CytoDyn Inc
10/04/2020 1:46:32 PM
Journal of Microbiology, Immunology
CYDY CytoDyn Inc
10/04/2020 12:04:39 PM
The author told me within a month, (1)
CYDY CytoDyn Inc
10/04/2020 11:57:45 AM
No
CYDY CytoDyn Inc
10/04/2020 11:35:39 AM
I meant to say is WILL be available
Go to page:
  • << First
  • < Previous
  • 9
  • 10
  • Next >

Recent Articles

  • Riding the Wave of Critical Minerals: Top ETF Picks
  • Market Rally: Major Stocks Surge After Earnings Surprise
  • Kansas City Life Insurance Reports Strong Q3 Performance
  • Emily Wells' Journey from Skeptic to Spiritual Wisdom
  • Exploring Faith through Dystopian Adventures in New Novel
  • The Craneware Group Prepares for 340B Rebate Model Launch
  • TrxNow Marks 11 Years of Revolutionary Roadside Assistance Service
  • Insights into the Steady U.S. Auto Market Performance
  • Reflecting on Education: Insights from a Veteran Teacher
  • LRS Leadership Team Earns National Recognition for Excellence
  • Why an SEO ROI Calculator Is Essential for Growth
  • Gold Port Expands Private Placement Amid High Market Demand
  • Sample Pay Stub Template: Learn How It Works in Practice
  • Discover BetWhale: The Premier PayPal Casino in 2025
  • Kansas City Life Shares Positive Quarterly Financial Results
  • JBT Marel Prepares for Quarterly Earnings Release Insights
  • Understanding Co-worker Support and Status Loss in Workplaces
  • CAP Index Unveils Innovative Scores to Assess Social Risks
  • Entergy Boosts Quarterly Dividend to Support Shareholders
  • Celebrating Innovations in CAR T-cell Therapy with the Merkin Prize
  • Georgia's Health Care Providers Join Forces to Enhance Care
  • DATTCO School Bus Workers Celebrate New Contract Success
  • AutoNation Unveils $1 Billion Stock Buyback Initiative
  • BetWhale: Your Ultimate Guide to Online Betting in 2025
  • Amazon's Strong Q3 Results Amidst Dow's Decline in Trading
  • Twilio Achieves Record Q3 Growth with Analyst Optimism
  • What Investors Need to Know About US Gold and Coin Appraisals
  • Gilead Sciences' Stellar Earnings Performance and Future Outlook
  • DATTCO Teamsters Secure Major Contract Wins for Workers
  • Join DFDS for Their Upcoming Q3 Conference Call Event
  • Join DFDS for an Engaging Q3 Conference Call Experience
  • Abcourt Mines Secures $10 Million Through Strategic Placement
  • Fagron's Recent Share Buyback: A Comprehensive Update
  • ETHWomen 2025: A New Era of Empowering Women in Web3
  • Avantor Faces Class Action Lawsuit Over Misleading Statements
  • Abcourt Mines Finalizes $10 Million Investment Strategy
  • Shopify's Earnings Expectation: Growth Ahead with Strategic Moves
  • Mastercard's Future Growth and Analyst Insights for Investors
  • THE 456 Unveils Their Debut EP 'Life on the Head of a Pin'
  • South Mountain Creamery's Turkey Drive: A Holiday Giving Tradition
  • Operational Leverage in a Downturn: Strategic Offshore Partners for Non-Core Ops
  • Elevate Your Enterprise: Join the Procurement Webinar
  • Explore the Dark Thrills of Poppy Playtime's Upcoming Chapter
  • Getty Images Flourishes with New AI Licensing Agreement
  • Introducing Templeton's First Single Barrel Rye Whiskey
  • Marvell Technology's Bright Future Fueled by AI Developments
  • Bloom Energy Corporation's Stock Update and Market Insights
  • Exploring Old National Inc's Earnings and Market Performance
  • Understanding Illumina's Options Market: Key Insights
  • Market Movements: Insights into Walmart's Stock Performance
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site